TG Therapeutics TGTX Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's common stock?
- TG Therapeutics (TGTX) reported common stock of $160K in Q1 2026.
- How has TG Therapeutics's common stock changed year-over-year?
- TG Therapeutics's common stock increased by 0.6% year-over-year, from $159K to $160K.
- What is the long-term trend for TG Therapeutics's common stock?
- Over 5 years (2020 to 2025), TG Therapeutics's common stock has grown at a 2.4% compound annual growth rate (CAGR), from $141K to $159K.
- What does common stock mean?
- The total par value of all common shares issued by the company.
- How do you interpret common stock?
- Changes usually reflect new share issuances or corporate restructuring rather than operational performance.
- How does common stock compare across companies?
- Generally stable across most public companies unless significant equity financing or stock splits occur.